EBANG INTERNATIONAL HLDGS-A (EBON) Fundamental Analysis & Valuation
NASDAQ:EBON • KYG3R33A2053
Current stock price
2.48 USD
-0.1 (-3.88%)
Last:
This EBON fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EBON Profitability Analysis
1.1 Basic Checks
- EBON had negative earnings in the past year.
- In the past 5 years EBON reported 4 times negative net income.
- EBON had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- EBON's Return On Assets of -6.92% is in line compared to the rest of the industry. EBON outperforms 50.00% of its industry peers.
- With a Return On Equity value of -7.31%, EBON perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.92% | ||
| ROE | -7.31% | ||
| ROIC | N/A |
ROA(3y)-10.81%
ROA(5y)-10.52%
ROE(3y)-11.56%
ROE(5y)-12.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- EBON's Gross Margin of 6.26% is on the low side compared to the rest of the industry. EBON is outperformed by 86.84% of its industry peers.
- In the last couple of years the Gross Margin of EBON has declined.
- The Profit Margin and Operating Margin are not available for EBON so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 6.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.03%
GM growth 5YN/A
2. EBON Health Analysis
2.1 Basic Checks
- EBON does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for EBON remains at a similar level compared to 1 year ago.
- The number of shares outstanding for EBON has been reduced compared to 5 years ago.
- EBON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- EBON has an Altman-Z score of 0.61. This is a bad value and indicates that EBON is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 0.61, EBON is doing worse than 71.05% of the companies in the same industry.
- EBON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.61 |
ROIC/WACCN/A
WACC8.95%
2.3 Liquidity
- A Current Ratio of 22.01 indicates that EBON has no problem at all paying its short term obligations.
- EBON has a Current ratio of 22.01. This is amongst the best in the industry. EBON outperforms 97.37% of its industry peers.
- EBON has a Quick Ratio of 21.91. This indicates that EBON is financially healthy and has no problem in meeting its short term obligations.
- EBON has a Quick ratio of 21.91. This is amongst the best in the industry. EBON outperforms 97.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 22.01 | ||
| Quick Ratio | 21.91 |
3. EBON Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 47.31% over the past year.
- The Revenue has grown by 154.42% in the past year. This is a very strong growth!
- Measured over the past years, EBON shows a very negative growth in Revenue. The Revenue has been decreasing by -44.26% on average per year.
EPS 1Y (TTM)47.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.51%
Revenue 1Y (TTM)154.42%
Revenue growth 3Y-51.52%
Revenue growth 5Y-44.26%
Sales Q2Q%69.46%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. EBON Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for EBON. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. EBON Dividend Analysis
5.1 Amount
- EBON does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EBON Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:EBON (4/24/2026, 8:00:01 PM)
2.48
-0.1 (-3.88%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)04-28 2025-04-28
Earnings (Next)N/A N/A
Inst Owners2.22%
Inst Owner Change0%
Ins Owners0.15%
Ins Owner Change0%
Market Cap15.57M
Revenue(TTM)7.34M
Net Income(TTM)-18.54M
Analysts0
Price TargetN/A
Short Float %0.34%
Short Ratio3.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.12 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.06 | ||
| P/tB | 0.06 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.95
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.17
BVpS40.39
TBVpS39.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.92% | ||
| ROE | -7.31% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 6.26% | ||
| FCFM | N/A |
ROA(3y)-10.81%
ROA(5y)-10.52%
ROE(3y)-11.56%
ROE(5y)-12.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.03%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 22.01 | ||
| Quick Ratio | 21.91 | ||
| Altman-Z | 0.61 |
F-ScoreN/A
WACC8.95%
ROIC/WACCN/A
Cap/Depr(3y)116.39%
Cap/Depr(5y)160.72%
Cap/Sales(3y)49.33%
Cap/Sales(5y)56.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)154.42%
Revenue growth 3Y-51.52%
Revenue growth 5Y-44.26%
Sales Q2Q%69.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.15%
OCF growth 3YN/A
OCF growth 5YN/A
EBANG INTERNATIONAL HLDGS-A / EBON Fundamental Analysis FAQ
What is the fundamental rating for EBON stock?
ChartMill assigns a fundamental rating of 3 / 10 to EBON.
What is the valuation status of EBANG INTERNATIONAL HLDGS-A (EBON) stock?
ChartMill assigns a valuation rating of 0 / 10 to EBANG INTERNATIONAL HLDGS-A (EBON). This can be considered as Overvalued.
How profitable is EBANG INTERNATIONAL HLDGS-A (EBON) stock?
EBANG INTERNATIONAL HLDGS-A (EBON) has a profitability rating of 1 / 10.
How financially healthy is EBANG INTERNATIONAL HLDGS-A?
The financial health rating of EBANG INTERNATIONAL HLDGS-A (EBON) is 7 / 10.